OptimizeRx (OPRX) Insider Trading & Ownership $7.75 -0.13 (-1.65%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$7.65 -0.10 (-1.29%) As of 04/4/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OptimizeRx (NASDAQ:OPRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.10%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$2.54 MNumber OfInsiders Selling(Last 12 Months)0 Get OPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling OptimizeRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OPRX Insider Buying and Selling by Quarter Remove Ads OptimizeRx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/14/2025James Paul LangDirectorBuy321,408$7.60$2,442,700.80 12/12/2024William J FebboCEOBuy20,000$5.01$100,200.00 (Data available from 1/1/2013 forward) OPRX Insider Trading Activity - Frequently Asked Questions Who is on OptimizeRx's Insider Roster? The list of insiders at OptimizeRx includes Edward Stelmakh, Ellen O'connor Vos, James Paul Lang, Marion Odence-Ford, Stephen L Silvestro, and William J Febbo. Learn more on insiders at OPRX. What percentage of OptimizeRx stock is owned by insiders? 6.10% of OptimizeRx stock is owned by insiders. Learn more on OPRX's insider holdings. Which OptimizeRx insiders have been buying company stock? The following insiders have purchased OPRX shares in the last 24 months: James Paul Lang ($2,442,700.80), and William J Febbo ($100,200.00). How much insider buying is happening at OptimizeRx? Insiders have purchased a total of 341,408 OPRX shares in the last 24 months for a total of $2,542,900.80 bought. Which OptimizeRx insiders have been selling company stock? The following insider sold OPRX shares in the last 24 months: Marion Odence-Ford ($60,760.00). How much insider selling is happening at OptimizeRx? Insiders have sold a total of 4,000 OptimizeRx shares in the last 24 months for a total of $60,760.00 sold. OptimizeRx Key ExecutivesMr. William J. Febbo (Age 55)CEO & Director Compensation: $863.15k1 recent tradesMr. Stephen L. Silvestro (Age 46)President Compensation: $591.62kMr. Edward Stelmakh C.M.A. (Age 58)M.B.A., CFO & COO Compensation: $626.74kMr. Andrew Jacob D'SilvaSenior Vice President of Corporate Finance More Insider Trading Tools from MarketBeat Related Companies MediaAlpha Insider Selling Willdan Group Insider Selling Accolade Insider Selling Thryv Insider Selling Repay Insider Selling Priority Technology Insider Selling Enviri Insider Selling Montrose Environmental Group Insider Selling Advantage Solutions Insider Selling Conduent Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:OPRX) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OPRX Stock Free OPRX Stock Alerts